World Drug Safety Congress EU 2026
World Drug Safety Congress Europe 2026
Date: 23rd-24th September 2026
Location: Amsterdam, Netherlands
Booth: #514
PharSafer is pleased to be returning to World Patient Safety Congress Europe 2026, bringing together pharmacovigilance, patient safety and drug safety professionals from across the global life sciences industry.
As the pharmacovigilance landscape continues to evolve, safety teams are navigating increasingly complex operational and regulatory demands – from growing case volumes and global oversight requirements to changing data sources, outsourcing models and the increasing role of automation.
Throughout WPSC Europe, the PharSafer team will be available at Booth #514 to discuss these challenges and how organisations can build more scalable, consistent and effective pharmacovigilance operations.
Meet PharSafer at Booth #514
Whether you’re reviewing your current pharmacovigilance model, preparing for changing requirements or looking for practical ways to improve efficiency and oversight, our team would welcome the opportunity to discuss your priorities.
Key areas we’ll be discussing at WPSC Europe include:
- Clinical & Post-Marketing Pharmacovigilance
- Global PV Outsourcing & Flexible Resource Support
- Vendor Selection, Governance & Oversight
- Pharmacovigilance Audits & Inspection Readiness
- Global Regulatory Strategy & Compliance
- Medical Affairs & Safety Communication
- QPPV/LPPV Support
- Safety Automation & Workflow Innovation with RAPTAR®
Hear from Dr Graeme Ladds
Outsourced Pharmacovigilance: Why It Still Feels Inconsistent – and How to Regain Control
Date: Wednesday 23rd September 2026
Time: 12:20-12:40 PM
Location: Outsourcing | E108
Outsourcing pharmacovigilance is intended to improve flexibility and scalability – yet inconsistency remains a persistent challenge.
Variability can begin at the point of vendor selection, where limited or inconsistent pre-qualification, minimal assessment of competency and cost-driven decisions can introduce risk from the outset.
This can then be compounded during onboarding and over time, where differences in process design, interpretation and quality management systems can impact consistency.
While oversight mechanisms such as SLAs and KPIs provide visibility, they do not always deliver control. As a result, organisations can find themselves increasing governance effort without achieving consistent outcomes.
In this session, Dr Graeme Ladds, CEO of PharSafer, will explore where these challenges emerge across the outsourcing lifecycle and practical approaches organisations can take to regain greater consistency and control.
Key discussion areas:
- Why variability can persist across outsourced pharmacovigilance models
- Common gaps in vendor selection, pre-qualification and competency assessment
- How onboarding and QMS integration can influence consistency over time
- The limitations of traditional oversight approaches, including SLAs and quality metrics
- Maintaining quality as people, processes, systems and requirements change
- Practical approaches to improving standardisation and control across global outsourced operations
Pharmacovigilance is changing. Are your operations keeping pace?
WPSC Europe comes at a time of continued change across the pharmacovigilance landscape.
Organisations are considering how to adopt AI and automation while maintaining appropriate governance and oversight, respond to evolving regulatory expectations, manage increasingly diverse sources of safety data, accommodate growing case volumes, and maintain quality across increasingly complex global operating models.
For many safety teams, the challenge isn’t simply responding to one individual development – it’s ensuring that people, processes, technology and quality systems continue to evolve together.
PharSafer provides specialist support across the product lifecycle, helping organisations respond to changing requirements while maintaining the quality, scalability and oversight required for effective patient safety.
How PharSafer can support you
Our global team can provide tailored support across:
- End-to-End Pharmacovigilance & Case Processing
- Global, Regional & Local QPPV/LPPV Services
- Signal Detection & Benefit-Risk Management
- Aggregate Reporting & Risk Management Planning
- Pharmacovigilance Audits & Vendor Oversight
- Inspection Readiness & QMS Support
- Regulatory Strategy & Compliance
- Medical Information & Medical Affairs
- Flexible FTE & Overflow Resource Support
- Safety Database & Computer System Validation Support
- Automation & Structured Safety Data Capture with RAPTAR®
Let’s meet in Amsterdam
If you’re attending World Patient Safety Congress Europe 2026, we’d love to hear about the challenges and priorities currently shaping your pharmacovigilance operations.
Visit the PharSafer team at Booth #514, join Graeme’s session on Wednesday 23rd September, or arrange a dedicated meeting with our team during the Congress.
World Patient Safety Congress Europe 2026
23-24 September 2026
Amsterdam, Netherlands
Booth #514
Not attending WPSC Europe this year?
You can still get in touch with our team to discuss your pharmacovigilance requirements.